Literature DB >> 24573674

Monoacylglycerol acyltransferase-2 is a tetrameric enzyme that selectively heterodimerizes with diacylglycerol acyltransferase-1.

Jun Zhang1, Dan Xu, Jia Nie, Jingsong Cao, Yonggong Zhai, Dewen Tong, Yuguang Shi.   

Abstract

Acyl-CoA:monoacylglycerol acyltransferases (MGATs) and diacylglycerol acyltransferases (DGATs) catalyze the two consecutive steps in the synthesis of triacylglycerol, a key process required for dietary fat absorption into the enterocytes of the small intestine. In this report, we investigated the tendency of MGAT2 to form an enzyme complex with DGAT1 and DGAT2 in intact cells. We demonstrated that in addition to the 38-kDa monomer of the MGAT2 enzyme predicted by its peptide sequence, a 76-kDa moiety was detected in SDS-PAGE without reducing agent and heat inactivation. The 76-kDa MGAT2 moiety was greatly enhanced by treatment with a cross-linking reagent in intact cells. Additionally, the cross-linking reagent dose-dependently yielded a band corresponding to the tetramer (152 kDa) in SDS-PAGE, suggesting that the MGAT2 enzyme primarily functions as a homotetrameric protein and as a tetrameric protein. Likewise, DGAT1 also forms a homodimer under nondenaturing conditions. When co-expressed in COS-7 cells, MGAT2 heterodimerized with DGAT1 without treatment with a cross-linking reagent. MGAT2 also co-eluted with DGAT1 on a gel filtration column, suggesting that the two enzymes form a complex in intact cells. In contrast, MGAT2 did not heterodimerize with DGAT2 when co-expressed in COS-7 cells, despite high sequence homology between the two enzymes. Furthermore, systematic deletion analysis demonstrates that N-terminal amino acids 35-80 of DGAT1, but not a signal peptide at the N terminus of MGAT2, is required for the heterodimerization. Finally, co-expression of MGAT2 with DGAT1 significantly increased lipogenesis in COS-7 cells, indicating the functional importance of the dimerization.

Entities:  

Keywords:  Diabetes; Diacylglycerol; Lipid Absorption; Lipid Metabolism; Metabolism

Mesh:

Substances:

Year:  2014        PMID: 24573674      PMCID: PMC4036202          DOI: 10.1074/jbc.M113.530022

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  34 in total

1.  Identification and preliminary characterization of a potent, safe, and orally efficacious inhibitor of acyl-CoA:diacylglycerol acyltransferase 1.

Authors:  Vince S C Yeh; David W A Beno; Sevan Brodjian; Michael E Brune; Steven C Cullen; Brian D Dayton; Madhup K Dhaon; Hugh D Falls; Ju Gao; Nelson Grihalde; Philip Hajduk; T Matthew Hansen; Andrew S Judd; Andrew J King; Russel C Klix; Kelly J Larson; Yau Y Lau; Kennan C Marsh; Scott W Mittelstadt; Dan Plata; Michael J Rozema; Jason A Segreti; Eric J Stoner; Martin J Voorbach; Xiaojun Wang; Xili Xin; Gang Zhao; Christine A Collins; Bryan F Cox; Regina M Reilly; Philip R Kym; Andrew J Souers
Journal:  J Med Chem       Date:  2012-02-10       Impact factor: 7.446

2.  Deficiency of MGAT2 increases energy expenditure without high-fat feeding and protects genetically obese mice from excessive weight gain.

Authors:  David W Nelson; Yu Gao; Nicole M Spencer; Taylor Banh; Chi-Liang Eric Yen
Journal:  J Lipid Res       Date:  2011-07-06       Impact factor: 5.922

3.  Diacylglycerol acyltransferase-1 inhibition enhances intestinal fatty acid oxidation and reduces energy intake in rats.

Authors:  Gudrun Schober; Myrtha Arnold; Susan Birtles; Linda K Buckett; Gustavo Pacheco-López; Andrew V Turnbull; Wolfgang Langhans; Abdelhak Mansouri
Journal:  J Lipid Res       Date:  2013-02-28       Impact factor: 5.922

4.  Identification and design of a novel series of MGAT2 inhibitors.

Authors:  Jonas G Barlind; Linda K Buckett; Sharon G Crosby; Öjvind Davidsson; Hans Emtenäs; Anne Ertan; Ulrik Jurva; Malin Lemurell; Pablo Morentin Gutierrez; Karolina Nilsson; Gavin O'Mahony; Annika U Petersson; Alma Redzic; Fredrik Wågberg; Zhong-Qing Yuan
Journal:  Bioorg Med Chem Lett       Date:  2013-02-27       Impact factor: 2.823

Review 5.  Glycerolipid acyltransferases in triglyceride metabolism and energy homeostasis-potential as drug targets.

Authors:  Guoqing Cao; Robert J Konrad; Shuyu D Li; Craig Hammond
Journal:  Endocr Metab Immune Disord Drug Targets       Date:  2012-06       Impact factor: 2.895

6.  Acute changes in the response to peripheral leptin with alteration in the diet composition.

Authors:  L Lin; R Martin; A O Schaffhauser; D A York
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2001-02       Impact factor: 3.619

7.  Evidence that diacylglycerol acyltransferase 1 (DGAT1) has dual membrane topology in the endoplasmic reticulum of HepG2 cells.

Authors:  Haja R Wurie; Linda Buckett; Victor A Zammit
Journal:  J Biol Chem       Date:  2011-08-16       Impact factor: 5.157

8.  Targeting Acyl-CoA:diacylglycerol acyltransferase 1 (DGAT1) with small molecule inhibitors for the treatment of metabolic diseases.

Authors:  Jingsong Cao; Yingjiang Zhou; Haibing Peng; Xinyi Huang; Shannon Stahler; Vipin Suri; Ariful Qadri; Tiffany Gareski; Juli Jones; Seung Hahm; Mylene Perreault; John McKew; Mengxiao Shi; Xin Xu; James F Tobin; Ruth E Gimeno
Journal:  J Biol Chem       Date:  2011-10-11       Impact factor: 5.157

9.  Lipopenia and skin barrier abnormalities in DGAT2-deficient mice.

Authors:  Scot J Stone; Heather M Myers; Steven M Watkins; Barbara E Brown; Kenneth R Feingold; Peter M Elias; Robert V Farese
Journal:  J Biol Chem       Date:  2003-12-10       Impact factor: 5.157

10.  MGAT2 deficiency ameliorates high-fat diet-induced obesity and insulin resistance by inhibiting intestinal fat absorption in mice.

Authors:  Takuma Tsuchida; Sayaka Fukuda; Hisanori Aoyama; Nobuhiko Taniuchi; Tomomi Ishihara; Noriko Ohashi; Hiroko Sato; Koji Wakimoto; Masaharu Shiotani; Akira Oku
Journal:  Lipids Health Dis       Date:  2012-06-14       Impact factor: 3.876

View more
  9 in total

1.  MoGAT-2 Inhibitors May Provide Effective Treatment for Hypertriglyceridemia.

Authors:  Ahmed F Abdel-Magid
Journal:  ACS Med Chem Lett       Date:  2014-06-06       Impact factor: 4.345

Review 2.  Intestinal triacylglycerol synthesis in fat absorption and systemic energy metabolism.

Authors:  Chi-Liang Eric Yen; David W Nelson; Mei-I Yen
Journal:  J Lipid Res       Date:  2014-09-17       Impact factor: 5.922

3.  Diacylglycerol acyltransferase-2 (DGAT2) and monoacylglycerol acyltransferase-2 (MGAT2) interact to promote triacylglycerol synthesis.

Authors:  Youzhi Jin; Pamela J McFie; Shanna L Banman; Curtis Brandt; Scot J Stone
Journal:  J Biol Chem       Date:  2014-08-27       Impact factor: 5.157

4.  Genome-wide analysis of microRNAs identifies the lipid metabolism pathway to be a defining factor in adipose tissue from different sheep.

Authors:  Xiangyang Miao; Qingmiao Luo; Xiaoyu Qin; Yuntao Guo
Journal:  Sci Rep       Date:  2015-12-22       Impact factor: 4.379

5.  Two Predicted Transmembrane Domains Exclude Very Long Chain Fatty acyl-CoAs from the Active Site of Mouse Wax Synthase.

Authors:  Steffen Kawelke; Ivo Feussner
Journal:  PLoS One       Date:  2015-12-29       Impact factor: 3.240

6.  Monoacylglycerol O-acyltransferase 1 (MGAT1) localizes to the ER and lipid droplets promoting triacylglycerol synthesis.

Authors:  Yoo Jeong Lee; Jae-Woo Kim
Journal:  BMB Rep       Date:  2017-07       Impact factor: 4.778

7.  Structure and mechanism of human diacylglycerol O-acyltransferase 1.

Authors:  Lie Wang; Hongwu Qian; Yin Nian; Yimo Han; Zhenning Ren; Hanzhi Zhang; Liya Hu; B V Venkataram Prasad; Arthur Laganowsky; Nieng Yan; Ming Zhou
Journal:  Nature       Date:  2020-05-13       Impact factor: 49.962

8.  De novo labeling and trafficking of individual lipid species in live cells.

Authors:  Jun Zhang; Jia Nie; Haoran Sun; Jie Li; John-Paul Andersen; Yuguang Shi
Journal:  Mol Metab       Date:  2022-05-02       Impact factor: 8.568

9.  An alternative angiosperm DGAT1 topology and potential motifs in the N-terminus.

Authors:  Somrutai Winichayakul; Amy Curran; Roger Moraga; Ruth Cookson; Hong Xue; Tracey Crowther; Marissa Roldan; Greg Bryan; Nick Roberts
Journal:  Front Plant Sci       Date:  2022-09-16       Impact factor: 6.627

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.